Ronald Sobecks

Ronald Sobecks

UNVERIFIED PROFILE

Are you Ronald Sobecks?   Register this Author

Register author
Ronald Sobecks

Ronald Sobecks

Publications by authors named "Ronald Sobecks"

Are you Ronald Sobecks?   Register this Author

96Publications

2674Reads

16Profile Views

Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma.

Transpl Infect Dis 2019 Aug 1;21(4):e13114. Epub 2019 Jun 1.

Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13114DOI Listing
August 2019

Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.

J Clin Apher 2019 Aug 5. Epub 2019 Aug 5.

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21739DOI Listing
August 2019

Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.

Hematol Oncol Stem Cell Ther 2018 Dec 24;11(4):253-256. Epub 2018 Apr 24.

Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S16583876183003
Publisher Site
http://dx.doi.org/10.1016/j.hemonc.2018.03.006DOI Listing
December 2018

Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 05 31;24(5):1029-1034. Epub 2018 Jan 31.

Blood and Marrow Transplantation Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953837PMC
May 2018

Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2016 06 16;22(6):1141-1144. Epub 2016 Mar 16.

Blood and Marrow Transplantation Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.011DOI Listing
June 2016

Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes.

Clin Lymphoma Myeloma Leuk 2015 Aug 2;15(8):489-95. Epub 2015 Apr 2.

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.03.017DOI Listing
August 2015

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.

Am J Hematol 2015 Feb 19;90(2):144-8. Epub 2014 Nov 19.

Blood & Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23882DOI Listing
February 2015

Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).

Biol Blood Marrow Transplant 2012 Jun 29;18(6):874-80. Epub 2011 Oct 29.

Taussig Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100457
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.10.032DOI Listing
June 2012

Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.

J Clin Apher 2011 6;26(3):111-5. Epub 2011 Jan 6.

Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.20278DOI Listing
November 2011

Vitamin D level after allogeneic hematopoietic stem cell transplant.

Biol Blood Marrow Transplant 2011 Jul 27;17(7):1079-83. Epub 2010 Dec 27.

Banner Blood and Marrow Transplant Program, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.12.704DOI Listing
July 2011

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).

Br J Haematol 2011 May 6;153(4):504-7. Epub 2011 Mar 6.

Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, The Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08607.xDOI Listing
May 2011

Race and intensity of post-remission therapy in acute myeloid leukemia.

Leuk Res 2011 Mar 8;35(3):346-50. Epub 2010 Aug 8.

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.07.020DOI Listing
March 2011

A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.

Cancer 2011 Mar 19;117(6):1253-61. Epub 2010 Oct 19.

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25686DOI Listing
March 2011

The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.

Br J Haematol 2011 Mar 12;152(5):561-9. Epub 2011 Jan 12.

Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2010.08549.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2010.08549.xDOI Listing
March 2011

Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.

Biol Blood Marrow Transplant 2010 Dec 14;16(12):1738-46. Epub 2010 Jun 14.

Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.06.009DOI Listing
December 2010

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia.

Cancer 2010 Aug;116(15):3614-20

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25086DOI Listing
August 2010

OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia.

Leuk Lymphoma 2010 Apr;51(4):606-12

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003592735DOI Listing
April 2010

Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.

Am J Hematol 2008 Nov;83(11):831-4

Department of Hematologic Malignancies and Blood Disorders, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21260DOI Listing
November 2008

Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.

Biol Blood Marrow Transplant 2008 Nov;14(11):1239-44

Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.08.009DOI Listing
November 2008

Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.

Leuk Lymphoma 2008 Aug;49(8):1560-6

Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, The Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802146078DOI Listing
August 2008

Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.

Cancer 2008 May;112(10):2233-40

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23394DOI Listing
May 2008

Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.

Leuk Res 2008 Mar 28;32(3):413-20. Epub 2007 Aug 28.

Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, 9500 Euclid Avenue R35, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.07.015DOI Listing
March 2008

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.

Cancer 2007 Oct;110(8):1752-9

Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22976
Publisher Site
http://dx.doi.org/10.1002/cncr.22976DOI Listing
October 2007

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia.

Leuk Lymphoma 2007 Aug;48(8):1561-8

Division of Hematology and Oncology, Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701474373DOI Listing
August 2007

High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant.

Clin Transplant 2006 Nov-Dec;20(6):783-7

Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1399-0012.2006.00581.x
Publisher Site
http://dx.doi.org/10.1111/j.1399-0012.2006.00581.xDOI Listing
February 2007

The role of post-remission chemotherapy for older patients with acute myelogenous leukemia.

Leuk Lymphoma 2006 Apr;47(4):689-95

Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500353554DOI Listing
April 2006

Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma.

Clin Lymphoma Myeloma 2005 Nov;6(3):248-50

Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2005.n.053DOI Listing
November 2005

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Cancer Chemother Pharmacol 2004 Dec 2;54(6):553-61. Epub 2004 Sep 2.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-004-0857-3
Publisher Site
http://dx.doi.org/10.1007/s00280-004-0857-3DOI Listing
December 2004

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Blood 2003 Jul 6;102(1):43-52. Epub 2003 Mar 6.

Section of Hematology/Oncology, Department of Medicine, MC2115, University of Chicago, 5841 S Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-11-3343DOI Listing
July 2003